Magnetar Financial LLC 13D and 13G filings for Meridian Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-19 08:16 am Unchanged | 2024-09-17 | 13D | Meridian Bioscience, Inc. VIVO | Magnetar Financial LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-03 2:06 pm Sale | 2023-01-31 | 13D | Meridian Bioscience, Inc. VIVO | Magnetar Financial LLC | 0 0.000% | -2,204,418 (Position Closed) | Filing |
| 2023-01-10 5:22 pm Purchase | 2023-01-06 | 13D | Meridian Bioscience, Inc. VIVO | Magnetar Financial LLC | 2,204,418 5.020% | 31,124 (+1.43%) | Filing |
| 2022-12-02 2:16 pm Sale | 2022-11-30 | 13D | Meridian Bioscience, Inc. VIVO | Magnetar Financial LLC | 2,173,294 4.960% | -87,394 (-3.87%) | Filing |
| 2022-11-02 7:48 pm Purchase | 2022-10-24 | 13D | Meridian Bioscience, Inc. VIVO | Magnetar Financial LLC | 2,260,688 5.170% | 12,363 (+0.55%) | Filing |
| 2022-09-19 12:23 pm Purchase | 2022-09-07 | 13D | Meridian Bioscience, Inc. VIVO | Magnetar Financial LLC | 2,248,325 5.140% | 2,248,325 (New Position) | Filing |